Journal of the American Pharmacists Association
Volume 49, Issue 5, Supplement 1, September–October 2009, Pages S3-S9
REVIEWSType 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategies
References (76)
Pathogenesis of type 2 diabetes mellitus
Med Clin North Am.
(2004)Pathogenesis of type 2 diabetes mellitus
Arch Med Res.
(2005)- et al.
Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives
Diabetes Metab.
(2007) - et al.
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Lancet.
(2006) - et al.
Pharmacist roles in the management of patients with type 2 diabetes
J Am Pharm Assoc.
(2009) The biology of incretin hormones
Cell Metab.
(2006)Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
J Am Pharm Assoc.
(2009)Efficacy and safety of incretin-based therapies: clinical trial data
J Am Pharm Assoc.
(2009)- et al.
trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study
Circulation.
(2006)
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care.
(2004)
Fact sheet number 311
Standards of medical care in diabetes—2008
Diabetes Care.
(2008)
Insulin action in man
Diabetes Metab.
(1996)
Glucose metabolism and regulation: beyond insulin and glucagon
Diabetes Spectrum.
(2004)
Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease
Diabetes.
(1995)
Is insulin resistance the principal cause of type 2 diabetes?
Diabetes Obes Metab.
(1999)
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study
Diabetes.
(1998)
Fate of the beta-cell in the pathophysiology of type 2 diabetes
J Am Pharm Assoc.
(2009)
Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006
Diabetes Care.
(2009)
Total prevalence of diabetes & pre-diabetes
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
N Engl J Med.
(2002)
Obesity among adults in the United States—no statistically significant change since 2003-2004
NCHS Data Brief.
(2007)
High body mass index for age among US children and adolescents, 2003-2006
JAMA.
(2008)
Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation.
(2007)
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004
Hypertension.
(2007)
Prevalence of overweight and obesity among adults with diagnosed diabetes—United States, 1988-1994 and 1999-2002
MMWR Morb Mortal Wkly Rep.
(2004)
Effect of BMI on lifetime risk for diabetes in the U.S
Diabetes Care.
(2007)
Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults
J Epidemiol Community Health.
(2000)
Impact of overweight on the risk of developing common chronic diseases during a 10-year period
Arch Intern Med.
(2001)
How many cases of type 2 diabetes mellitus are due to being overweight in middle age? Evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records
Diabet Med.
(2007)
Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study
Diabetes.
(2004)
Weight change and diabetes incidence: findings from a national cohort of US adults
Am J Epidemiol.
(1997)
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management
JAMA.
(2002)
Ronnemaa t, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
N Engl J Med.
(1998)
Cited by (116)
Microwave-assisted efficient synthesis of pyrazole-fibrate derivatives as stimulators of glucose uptake in skeletal muscle cells
2021, Bioorganic and Medicinal Chemistry LettersHesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats
2018, Chemico-Biological InteractionsPhysical exercise in chronic diseases
2018, Nutrition and Skeletal MuscleTreatment with high dose salicylates improves cardiometabolic parameters: Meta-analysis of randomized controlled trials
2017, Metabolism: Clinical and Experimental
Disclosure: Speakers' Bureau for Eli Lilly & Co., Daiichi-Sankyo. Otherwise, the author declares no conflicts of interest or financial interests in any product or service mentioned in this article, including grants, employment, gifts, stock holdings, or honoraria.
Acknowledgment: AdelphiEden Health Communications and Robert McCarthy, PhD, for medical editorial services.
Funding: Publication of the supplement to JAPhA made possible through an educational grant from Novo Nordisk Inc.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.